HIV VIRAL LOAD QUANTITATIVE Test

The HIV Viral Load Quantitative test measures the amount of HIV RNA (viral genetic material) present in a blood sample. The result is typically reported as the number of HIV RNA copies per millilitre (copies/mL) and is an important measure of the amount of virus circulating in the bloodstream.

The test is primarily used for people diagnosed with HIV to monitor the effectiveness of antiretroviral therapy (ART). A significant decrease in viral load after starting treatment generally indicates that the medication is suppressing HIV replication. Regular monitoring can also help healthcare providers identify inadequate treatment response or a possible increase in viral load.

An undetectable viral load means that HIV RNA is below the detection or quantification limit of the particular test. It does not mean that HIV has been completely eliminated from the body, so treatment should continue as prescribed by the healthcare provider.

Test Recommended for Individuals:

• Individuals diagnosed with HIV
• Patients starting antiretroviral therapy
• People monitoring their response to HIV treatment
• Individuals undergoing routine HIV viral load monitoring
• Patients whose treatment regimen has been changed
• People with a previously suppressed viral load requiring follow-up
• Individuals with suspected treatment failure or increasing viral load
• Patients advised by their healthcare provider to undergo quantitative HIV RNA testing

FAQs

1. What does the HIV Viral Load Quantitative test measure?
It measures the amount of HIV RNA in the blood, providing a numerical estimate of how much HIV is circulating in the body.

2. What does an undetectable HIV viral load mean?
It means the amount of HIV RNA is below the detection or quantification limit of the test. In people receiving effective ART, maintaining an undetectable viral load is a key treatment goal. It does not mean that HIV has been cured.

3. How often should HIV viral load be tested?
Testing frequency depends on the individual’s treatment status, previous viral load results, and healthcare provider’s recommendations. It is commonly performed at treatment initiation and periodically during treatment to assess and maintain viral suppression.